According to Reuters, Mixing doses of the AstraZeneca and Pfizer-BioNTech generate robust immune responses against the coronavirus, a study conducted by Oxford University has suggested. The study, called Com-COV, compared mixed two-dose schedules of Pfizer and AstraZeneca, and found that in any combination, they produced high concentrations of antibodies against the coronavirus spike protein. Notably, some of the European countries have already started offering alternatives to AstraZeneca as a second shot.
About Vaccines in India
For information about vaccination in India, visit www.cowin.gov.in
Also Read:
Vaccines Ineffective Against Spike Protein Changes In Covid-19 Variant | Surखियाँ (surkhiyaa.com)
Arjun Singh
Arjun Singh is the Co-Founder of Surkhiyaa and a youth Journalistic enthusiast who has strong hold on Content Writing and Mass Communication. With a vision of providing short and forthright news, he looks forward to make a difference in Journalism. Arjun can be reached out at as3314177@gmail.com
